Harrington Lauren A 4
4 · Aramark · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
Aramark (ARMK) EVP Lauren Harrington Exercises Options, Sells Shares
What Happened
Lauren A. Harrington, Executive Vice President and General Counsel of Aramark (ARMK), exercised vested stock options and immediately sold the resulting shares on May 18, 2026. She exercised 8,852 options at $24.58 (acquisition cost $217,582) and 9,511 options at $29.38 (acquisition cost $279,433), receiving 18,363 shares in total. Those shares were sold in the open market: 8,852 shares at a weighted average price of $53.09 (proceeds $469,950) and 9,511 shares at a weighted average price of $53.02 (proceeds $504,278), for combined gross proceeds of approximately $974,228. The filing also reports the related derivative instruments as disposed (reported at $0) consistent with option exercises.
Key Details
- Transaction date: May 18, 2026; Form 4 filed May 19, 2026 (timely filing).
- Options exercised: 8,852 @ $24.58 and 9,511 @ $29.38 (total exercise cost $497,015).
- Shares sold: 8,852 @ weighted avg $53.09 (range $53.080–$53.130) and 9,511 @ weighted avg $53.02 (range $53.010–$53.080). Combined sale proceeds ≈ $974,228. (Footnotes offer per-price breakdown on request.)
- Post-transaction share ownership: Not specified in the provided excerpt of the filing.
- Notable footnotes: Options exercised were fully vested; the exercised options expire Nov 18, 2026 and Nov 16, 2027 (footnotes F3, F4). Footnotes F1/F2 note weighted-average sale prices and ranges, with an undertaking to provide per-price details on request.
Context
This was an exercise of vested options followed by an immediate open-market sale of the shares (a cashless exercise pattern). Such transactions often reflect routine option exercises and liquidity needs rather than a directional signal about company prospects. The filing is factual and timely; it does not disclose any trading plan (e.g., 10b5-1) in the provided excerpt.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-05-18$24.58/sh+8,852$217,582→ 135,706.31 total - Sale
Common Stock
[F1]2026-05-18$53.09/sh−8,852$469,950→ 126,854.31 total - Exercise/Conversion
Common Stock
2026-05-18$29.38/sh+9,511$279,433→ 136,365.31 total - Sale
Common Stock
[F2]2026-05-18$53.02/sh−9,511$504,278→ 126,854.31 total - Exercise/Conversion
Stock Option (Right to Buy)
[F3]2026-05-18−8,852→ 0 totalExercise: $24.58Exp: 2026-11-18→ Common Stock (8,852 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F4]2026-05-18−9,511→ 0 totalExercise: $29.38Exp: 2027-11-16→ Common Stock (9,511 underlying)
Footnotes (4)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.080 to $53.130, inclusive. The reporting person undertakes to provide to Aramark, any security holder of Aramark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.010 to $53.080, inclusive. The reporting person undertakes to provide to Aramark, any security holder of Aramark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]These options are fully vested and will expire on November 18, 2026.
- [F4]These options are fully vested and will expire on November 16, 2027.